Life after a heart attack
https://libcat.nshealth.ca/en/permalink/chpams34348
Nova Scotia Health Authority. Heart Health Portfolio.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0016
- Available Online
- View Pamphlet
This pamphlet answers questions you may have after having a heart attack. Lowering your risk factors for heart disease, heart healthy eating, coping with stress, activity, exercises, checking your heart rate, warning signs you are doing too much, medications and how to use nitro spray are covered. Directions for managing chest pain or discomfort at home are given.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Heart Health Portfolio
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (37 p.) : digital, PDF file
- Subjects (MeSH)
- Myocardial Infarction - prevention & control
- Myocardial infarction - rehabilitation
- Heart Diseases - prevention & control
- Subjects (LCSH)
- Myocardial infarction
- Heart--Diseases--Patients--Rehabilitation
- Specialty
- Cardiovascular system
- Abstract
- This pamphlet answers questions you may have after having a heart attack. Lowering your risk factors for heart disease, heart healthy eating, coping with stress, activity, exercises, checking your heart rate, warning signs you are doing too much, medications and how to use nitro spray are covered. Directions for managing chest pain or discomfort at home are given.
- Responsibility
- Prepared by: Heart Health Portfolio
- Pamphlet Number
- 0016
Management of Myocardial Reperfusion Injury
https://libcat.nshealth.ca/en/permalink/provcat31045
Juan Carlos Kaski ... [et al.], editors.
--London:
Springer
, c2012.
- Available Online
- View e-Book
- Location
- Online
Much has been written about myocardial reperfusion injury and the controversies surrounding its existence and clinical relevance in the past 20 to 30 years. Unfortunately, however, there is little published information that integrates research findings with the practical aspects of its management and this has hindered the analysis of the clinical impact of the condition and its management. The pathophysiology and molecular mechanisms of myocardial reperfusion injury are complex, while individu…
- Available Online
- View e-Book
- Other Authors
- Kaski, Juan Carlos
- Responsibility
- Juan Carlos Kaski ... [et al.], editors
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2012
- Physical Description
- 1 online resource (xv, 305 p. : 55 ill., 28 ill. in color)
- ISBN
- 9781849960199
- Subjects (MeSH)
- Myocardial Infarction - prevention & control
- Myocardial Ischemia - prevention & control
- Myocardial Reperfusion Injury - diagnosis
- Myocardial Reperfusion Injury - physiopathology
- Myocardial Reperfusion Injury - therapy
- Subjects (LCSH)
- Cardiology
- Heart - Surgery
- Abstract
- Much has been written about myocardial reperfusion injury and the controversies surrounding its existence and clinical relevance in the past 20 to 30 years. Unfortunately, however, there is little published information that integrates research findings with the practical aspects of its management and this has hindered the analysis of the clinical impact of the condition and its management. The pathophysiology and molecular mechanisms of myocardial reperfusion injury are complex, while individual diagnostic techniques have been proposed but without a proper assessment of the relative values of these methods. The management of this condition has also been problematic, as therapeutic strategies that demonstrate prevention of myocardial reperfusion injury in experimental models have not translated into beneficial treatment strategies for patients. Management of Myocardial Reperfusion Injury brings together leading cardiovascular researchers and cardiologists to provide a comprehensive and critical review of the issues. Existing and novel therapeutic strategies for preventing myocardial reperfusion injury are discussed in depth, which will result in this being a vital reference for cardiologists and all healthcare professionals with an interest in the pathogenesis and management of myocardial damage. Cardiologists in training will find this monographic work to be an invaluable formative tool. This book will hopefully assist in further reducing the morbidity and mortality resulting from acute myocardial infarction.
- Contents
- Part I. Introduction -- 1. Myocardial Reperfusion Injury as a New Frontier for Clinical Therapy -- Part II. The Pathophysiology of Myocardial Reperfusion Injury: From a Pre-clinical Phenomenon to a New Target for Cardioprotection -- 2. Pathophysiology of Myocardial Reperfusion Injury -- 3. Microvascular Obstruction: The No-Reflow Phenomenon in Animal Models of Myocardial Ischemia and Reperfusion -- 4. Lethal Myocardial Reperfusion Injury -- 5. Translating Cardioprotective Strategies into Clinical Settings -- Part III. Diagnosis of Myocardial Reperfusion Injury: Assessment and Quantification -- 6. Cardiac Catheter Laboratory -- 7. Echocardiography in Myocardial Reperfusion Injury -- 8. Nuclear Imaging to Assess Infarction, Reperfusion, No-Reflow, and Viability -- 9. Role of Cardiovascular Magnetic Resonance in the Assessment of Patients with Acute Myocardial Infarction -- Part IV. Management of Myocardial Reperfusion Injury -- 10. Current Approaches to Prevention and Management of Reperfusion Injury -- 11. Endogenous Cardioprotective Strategies -- 12. Novel Treatment Strategies -- 13. Future Perspectives -- Index.
- Format
- e-Book
- Location
- Online
Nova Scotia Health Authority. QEII. Cardiology.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1496
- Available Online
- View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Cardiology
- Alternate Title
- Brilinta
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Platelet Aggregation Inhibitors - therapeutic use
- Adenosine - therapeutic use
- Cardiovascular Diseases - prevention & control
- Myocardial Infarction - prevention & control
- Pulmonary Embolism - prevention & control
- Subjects (LCSH)
- Adenosine
- Anticoagulants (Medicine)
- Cardiovascular system--Diseases--Prevention
- Myocardial infarction--Prevention
- Abstract
- Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
- Responsibility
- Prepared by: Cardiology
- Pamphlet Number
- 1496
